SHIRLEY, N.Y., Oct. 19, 2023 /PRNewswire/ -- American Regent announces the launch and availability of Potassium Phosphates Injection, USP, which is FDA-approved and therapeutically equivalent to ...
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that it has received New Drug Application (“NDA”) approval from the U.S.
BRIDGEWATER, N.J. - Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) has received approval from the U.S. Food and Drug Administration (FDA) for its novel intravenous (IV) potassium phosphates product in 0.9 ...
American Regent is offering Potassium Phosphates Injection, which is the generic of Potassium Phosphates. Potassium Phosphates Injection is indicated as a source of phosphorus in intravenous fluids to ...
FDA-approved option for adult and pediatric patients available in 15 mM per 5 mL, 45 mM per 15 mL and 150 mM per 50 mL presentations LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today ...
in intravenous fluids to correct hypophosphatemia in adults and pediatric patients when oral or enteral replacement is not possible, insufficient or contraindicated for parenteral nutrition in adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results